Drug firm Zydus Cadila on Wednesday said it has commenced supplies of its COVID-19 vaccine ZyCoV-D to the central government. Photograph: Kind courtesy Zydus Cadila The company has initiated the......
Drug firm Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Indian drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture......
Zydus Cadila's COVID-19 vaccine ZyCoV-D will initially be used in seven states, including Maharashtra, Tamil Nadu, Uttar Pradesh and West Bengal, which have been recommended to identify the......
Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market. ......
Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on......
Can Interferon alfa-2b treat COVID-19 effectively?Sohini Dutt reports. Kindly note the image has been posted only for representational purposes. Photograph: PTI Photo Ahmedabad-based......
The significant violations included the failure of the company to adequately probe or take corrective action after customer complaints between 2011 and 2012 about unpleasant odours from, and......
Cadila Healthcare Ltd said on Thursday, said German Remedies, a part of the Zydus Group, has launched Fludara Oral (Fludarabine) in the Indian market for the treatment of chronic lymphocytic......
Pharma major Zydus Cadila on Thursday entered into an agreement with Mayne Pharma of Australia to set up a 50:50 joint venture company to manufacture generic injectible cytotoxic (anti-cancer)......
Cadila Healthcare along with Zydus Wellness will acquire Heinz India in a deal worth Rs 4,595 crore, a regulatory filing said on Wednesday. The two companies have signed definitive agreements......